Maria Teresa Petrucci

Maria Teresa Petrucci

UNVERIFIED PROFILE

Are you Maria Teresa Petrucci?   Register this Author

Register author
Maria Teresa Petrucci

Maria Teresa Petrucci

Publications by authors named "Maria Teresa Petrucci"

Are you Maria Teresa Petrucci?   Register this Author

100Publications

2979Reads

20Profile Views

The Anti-CD38 Antibody Therapy in Multiple Myeloma.

Cells 2019 Dec 12;8(12). Epub 2019 Dec 12.

Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Via Benevento 6, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells8121629DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952883PMC
December 2019

Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.

Hematol Oncol 2019 Apr 7;37(2):117-128. Epub 2018 Sep 7.

Division of Hematology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2539DOI Listing
April 2019

Biventricular assessment of light-chain amyloidosis using 3D speckle tracking echocardiography: Differentiation from other forms of myocardial hypertrophy.

Int J Cardiol 2018 Nov 23;271:371-377. Epub 2018 Jul 23.

Department of Cardiology, Sapienza University, Rome, Italy; Department of Hematology, Sapienza University, Rome, Italy; Department of Medicine, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01675273173638
Publisher Site
http://dx.doi.org/10.1016/j.ijcard.2018.03.088DOI Listing
November 2018

Drug-Induced Senescent Multiple Myeloma Cells Elicit NK Cell Proliferation by Direct or Exosome-Mediated IL15 -Presentation.

Cancer Immunol Res 2018 07 24;6(7):860-869. Epub 2018 Apr 24.

Department of Molecular Medicine, Sapienza University of Rome, Istituto Pasteur Italia, Fondazione Cenci Bolognetti, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0604DOI Listing
July 2018

Proteasome inhibitors for the treatment of multiple myeloma.

Expert Opin Pharmacother 2018 03 26;19(4):375-386. Epub 2018 Feb 26.

a Hematology, Department of Cellular Biotechnologies and Hematology , "Sapienza" University , Rome , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2018.1441287DOI Listing
March 2018

Bortezomib, melphalan, and prednisone in elderly relapsed/refractory multiple myeloma patients: update of multicenter, open-label Phase 1/2 study.

Leuk Lymphoma 2017 11 12;58(11):2738-2740. Epub 2017 Apr 12.

a Hematology Service, Department of Cellular Biotechnology and Hematology , ' Sapienza' University , Rome , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1307360DOI Listing
November 2017

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis.

J Clin Oncol 2017 Oct 25;35(29):3279-3289. Epub 2017 Jul 25.

Philip L. McCarthy, Roswell Park Cancer Institute, Buffalo, NY; Sarah A. Holstein, University of Nebraska Medical Center, Omaha, NE; Maria Teresa Petrucci, University La Sapienza; Antonio Palumbo, Takeda Italia, Rome; Patrizia Tosi, Rimini Hospital, Rimini; Sara Bringhen and Francesca Gay, University of Torino, Torino; Pellegrino Musto, Cancer Institute for Research and Care and The Referral Cancer Center of Basilicata, Rionero in Vulture, Italy; Paul G. Richardson and Kenneth C. Anderson, Dana-Farber Cancer Institute, Boston, MA; Cyrille Hulin and Gerald Marit, Bordeaux Centre Hospitalier Universitaire, Bordeaux; Denis Caillot, Dijon University Hospital Center, Dijon; Philippe Moreau, University Hospital Hôtel-Dieu, Nantes; Michel Attal, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; Sin-Ho Jung, Duke University, Durham, NC; and Zhinuan Yu, Benjamin Winograd, and Robert D. Knight, Celgene Corporation, Summit, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.6679DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652871PMC
October 2017

Innate immune activating ligand SUMOylation affects tumor cell recognition by NK cells.

Sci Rep 2017 09 5;7(1):10445. Epub 2017 Sep 5.

Department of Molecular Medicine, "Sapienza" University of Rome, Laboratory affiliated to Istituto Pasteur Italia - Fondazione Cenci Bolognetti, "Viale Regina Elena 291, 00161, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-10403-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585267PMC
September 2017

Solitary Plasmacytoma.

Mediterr J Hematol Infect Dis 2017 23;9(1):e2017052. Epub 2017 Aug 23.

Hematology, Department of Cellular Biotechnologies and Hematology, "Sapienza" University, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2017.052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584766PMC
August 2017

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.

J Clin Oncol 2016 10;34(30):3609-3617

Cyrille Hulin, Bordeaux Hospital University Center, Bourdeaux; Philippe Rodon, Centre Hospitalier de Périgueux, Périgueux; Brigitte Pégourié, Centre Hospitalier Regional Universitaire, Grenoble; Laurent Garderet, Centre Hospitalier Universitaire (CHU) Hôpital St-Antoine, Paris; Isabelle Azais, CHU Institut National de la Santé et de la Recherche Médicale (INSERM); Xavier Leleu, Hôpital de la Milétrie, CHU INSERM, Poitiers; Margaret Macro, CHU de Caen, Caen; Bruno Royer, University Hospital, Amiens; Thierry Facon, Hôpital Claude Huriez, Centre Hospitalier Régional Universitaire de Lille, Lille, France; Andrew Belch, Cross Cancer Institute, Edmonton, Alberta; Chaim Shustik, Royal Victoria Hospital; Richard LeBlanc, Hôpital Maisonneuve-Rosemont, Montreal, Quebec; Kevin Song, Vancouver General Hospital, Vancouver, British Columbia, Canada; Maria Teresa Petrucci, Azienda Policlinico Umberto I, University La Sapienza, Rome, Italy; Ulrich Dührsen, University Hospital of Essen, West German Cancer Center, Essen, Germany; Jin Lu, Peking University Institute of Hematology, People's Hospital, Beijing, China; Hannah Hunter, Derriford Hospital, Plymouth, United Kingdom; Richard Eek, Border Medical Oncology, Wodonga, Victoria, Australia; Heinz Gisslinger, Medizinische Universität Wien, Vienna, Austria; Shaker Dakhil, Cancer Center of Kansas, Wichita, KS; Cristina Goncalves, Hospital de Santo Antonio-Porto, Porto, Portugal; Ken Romeril, Wellington Hospital, Wellington, New Zealand; Chantal Doyen, Université Catholique de Louvain (UCL), CHU UCL Namur, Yvoir; Fritz Offner, Universitair Ziekenhuis Gent, Ghent, Belgium; Nicolas Leupin, Celgene International, Boudry, Switzerland; Vanessa Houck, Guang Chen, and Annette Ervin-Haynes, Celgene, Summit, NJ; and Meletios A. Dimopoulos, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7295DOI Listing
October 2016

Bendamustine and dexamethasone are an effective salvage regimen for patients with advanced multiple myeloma in a Home Care Unit program.

Leuk Lymphoma 2016 07 23;57(7):1716-8. Epub 2015 Dec 23.

a Department of Cellular Biotechnologies and Hematology , "Sapienza" University , Via Benevento 6 , Rome 00153 , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1106531DOI Listing
July 2016

Severe clavicular disease in multiple myeloma.

Br J Haematol 2016 06 10;173(6):820. Epub 2016 May 10.

Department of Cellular Biotechnologies and Haematology, Sapienza University of Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14108DOI Listing
June 2016

Managing treatment-related peripheral neuropathy in patients with multiple myeloma.

Blood Lymphat Cancer 2016 29;6:37-47. Epub 2016 Jun 29.

Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/BLCTT.S91251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467335PMC
June 2016

Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment.

Cancer Res 2015 Nov 5;75(22):4766-77. Epub 2015 Oct 5.

Department of Molecular Medicine-Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome, Rome, Italy. IRCCS, Neuromed, Pozzilli, IS, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-1320DOI Listing
November 2015

Genotoxic Stress Induces Senescence-Associated ADAM10-Dependent Release of NKG2D MIC Ligands in Multiple Myeloma Cells.

J Immunol 2015 Jul 12;195(2):736-48. Epub 2015 Jun 12.

Department of Molecular Medicine, "Sapienza" University of Rome, Rome 00161, Italy; Institute Pasteur-Fondazione Cenci Bolognetti, "Sapienza" University of Rome, 00161 Rome, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1402643DOI Listing
July 2015

Bendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data.

Leuk Lymphoma 2015 Mar 27;56(3):559-67. Epub 2014 Jun 27.

Department of Hematology, University of Turin , Turin , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.915545DOI Listing
March 2015

Autologous transplantation and maintenance therapy in multiple myeloma.

N Engl J Med 2014 Sep;371(10):895-905

From the Myeloma Unit, Division of Hematology, University of Turin (A.P., F.C., F.G., C. Cerrato, M.G., P.O., M.B.), and Unit of Clinical Epidemiology and Centro di Referimento per l'Epidemiologia-Piemonte, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino (A.E., G.C.), Turin, Division of Hematology, Ospedale Ferrarotto, Azienda Policlinico-Ospedale Vittorio Emanuele, University of Catania, Catania (F.D.R.), Hematology, Sapienza University of Rome (M.T.P.), and Cattedra di Ematologia, Ospedale S. Eugenio-University Tor Vergata (T.C.), Rome, Divisione di Ematologia, Ospedale S. Gerardo, Monza (S.P.), La Struttura Complessa di Ematologia, Dipartimento di Ematologia ed Oncologia, Azienda Ospedaliera Niguarda Ca' Granda (A.C.), Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute (M.M.), and Division of Hematology and Bone Marrow Transplantation, IRCCS Istituto Nazionale dei Tumori-University of Milan (P.C.), Milan, Ematologia, Policlinico Federico II, Naples (L.C.), Clinica di Ematologia, Azienda Ospedaliera Universitaria Ospedali Riuniti di Ancona, Ancona (M.O.), Unità Operativa Complessa Ematologia 1, IRCCS Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca sul Cancro, Genoa (A.M.C.), Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna (E.Z., M.C.), Clinica Ematologia, Dipartimento di Scienze Mediche Sperimentali e Cliniche, Azienda Ospedaliera-Universitaria di Udine, Udine (F.P.), Scientific Direction, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture (P.M.), and Struttura Complessa Ematologia e Dipartimento Oncologia Medica, Spedali Civili di Brescia, Brescia (C. Crippa) - all in Italy; and the Hematology Division, Hadassah University Hospital, Jerusalem (D.B.Y.), and the Hematology Institute, Chaim Sheba Medical Center, Tel Hashomer (E.R., A.N.) - both in Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1402888DOI Listing
September 2014

Combination of international scoring system 3, high lactate dehydrogenase, and t(4;14) and/or del(17p) identifies patients with multiple myeloma (MM) treated with front-line autologous stem-cell transplantation at high risk of early MM progression-related death.

J Clin Oncol 2014 Jul 2;32(20):2173-80. Epub 2014 Jun 2.

Philippe Moreau, University Hospital Hôtel-Dieu; Jean-Luc Harousseau, Centre Rene Gauducheau, Nantes; Michel Attal, Centre Hospitalier Universitaire (CHU) Toulouse; Hervé Avet-Loiseau, CHU Rangueil, Toulouse; Gerald Marit, University Hospital of Bordeaux, Bordeaux; Cyrille Hulin, CHU Nancy, Nancy; Thierry Facon, Hopital Claude Huriez; Xavier Leleu, University Hospital of Lille, Lille; Denis Caillot, CHU Dijon, Dijon; Lotfi Benboubker, Centre Hospitalier Régional Universitaire Tours, Tours; Jean-Yves Mary, University Hospital Paris Saint-Louis, Paris, France; Michele Cavo, Annalisa Pezzi, and Elena Zamagni, Seràgnoli Institute of Hematology, Bologna; Antonio Palumbo, University of Torino, Torino; Maria Teresa Petrucci, Sapienza University of Rome, Rome; Francesca Patriarca, University Hospital, Udine, Italy; Pieter Sonneveld, Erasmus Medical Center, Rotterdam; Bronno van der Holt, Daniel den Hoed Cancer Center at Erasmus Medical Center, Rotterdam; Henk Lokhorst, University Medical Center Utrecht, Utrecht, the Netherlands; Hartmut Goldschmidt, Universitätsklinikum Heidelberg; Kai Neben, University of Heidelberg, Heidelberg, Germany; Laura Rosinol and Joan Bladé, Hospital Clinic, Barcelona; Juan Jose Lahuerta, Hospital Universitario 12 de Octubre, Madrid; Jesus san Miguel, University of Salamanca; Norma Gutierrez, Hospital Universitario de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.0329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879712PMC
July 2014

Subcutaneous bortezomib for multiple myeloma treatment: patients' benefits.

Patient Prefer Adherence 2014 4;8:939-46. Epub 2014 Jul 4.

Department of Cellular Biotechnology and Hematology, Sapienza University of Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/PPA.S38142DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094627PMC
July 2014

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.

J Clin Oncol 2014 Mar 21;32(7):634-40. Epub 2014 Jan 21.

Antonio Palumbo, Sara Bringhen, Alessandra Larocca, Valeria Magarotto, Paola Omedé, Roberto Mina, Mario Boccadoro, and Giulia Benevolo, Azienda Ospedaliera (A.O.) Città della Salute e della Scienza di Torino; Daniela Gottardi, A.O. Ordine Mauriziano; Roberto Passera, San Giovanni Battista Hospital, University of Torino, Torino; Davide Rossi and Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara; Francesco Di Raimondo, Ferrarotto Hospital, University of Catania, Catania; Francesca Patriarca, A.O. Universitaria, Udine; Anna Levi and Maria Teresa Petrucci, Sapienza University of Rome; Luca Franceschini, Tor Vergata University Hospital, Rome; Iolanda Donatella Vincelli, A.O. Bianchi-Melacrino-Morelli, Reggio Calabria; Mariella Grasso, S. Croce e Carle Hospital, Cuneo; Renato Zambello, Università degli Studi di Padova, Padova; Vittorio Montefusco, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori Milano, University of Milano, Milan; Antonietta Pia Falcone, IRCCS Casa Sollievo della Sofferenza and Unità di Ematologia, San Giovanni Rotondo; Roberto Marasca, University of Modena, Modena; Fortunato Morabito, A.O. di Cosenza, Cosenza; Tommasina Guglielmelli, "S. Luigi Gonzaga" Hospital, Orbassano; Chiara Nozzoli, A.O. Universitaria Careggi, Firenze; Massimo Offidani, Ospedali Riuniti, Ancona; Roberto Ria, University of Bari "Aldo Moro" Medical School, Bari; Pellegrino Musto, IRCCS-Centro Regionale Oncologico Basilicata, Rionero in Vulture; and Michele Cavo, Università degli Studi di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.0023DOI Listing
March 2014

Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapy.

Clin Cancer Res 2013 Aug 12;19(15):4249-61. Epub 2013 Jun 12.

Department of Hematology Oncology and Molecular Medicine, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome 00161, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3666DOI Listing
August 2013

Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma.

Support Care Cancer 2012 Oct 15;20(10):2621-6. Epub 2012 Jun 15.

Hematology, Department of Haematology, Oncology, Pathology and Regenerative Medicine, Policlinico Umberto I, Sapienza University Rome, Rome, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-012-1511-y
Publisher Site
http://dx.doi.org/10.1007/s00520-012-1511-yDOI Listing
October 2012

Bortezomib a safe treatment for patients with multiple myeloma and cystic fibrosis.

Mediterr J Hematol Infect Dis 2012 7;4(1):e2012035. Epub 2012 May 7.

Hematology, "Sapienza" University of Rome. Via Benevento 6, 00161 Rome (Italy).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2012.035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375716PMC
October 2012

Efficacy of bortezomib in systemic extramedullary localizations of multiple myeloma.

Clin Adv Hematol Oncol 2012 Apr;10(4):266-8

Department of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy.

View Article

Download full-text PDF

Source
April 2012

Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma.

Eur J Haematol 2010 Sep 8;85(3):200-8. Epub 2010 May 8.

Department of Internal Medicine, Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2010.01469.xDOI Listing
September 2010

Relapse of IgA lambda multiple myeloma presenting as obstructive jaundice and abdominal pain.

Onkologie 2009 Mar 18;32(3):119-21. Epub 2009 Feb 18.

Hematology, University Campus Bio-Medico, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000197687DOI Listing
March 2009

The effects of alendronate treatment in osteoporotic patients affected by monoclonal gammopathy of undetermined significance.

Calcif Tissue Int 2008 Jun;82(6):418-26

Department of Clinical Sciences, University "La Sapienza", Viale del Policlinico 155, 00161 Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00223-008-9145-2DOI Listing
June 2008

New therapeutic protocol in the treatment of avascular necrosis of the jaws.

J Craniofac Surg 2006 Nov;17(6):1080-3

Department of Maxillo-Facial Surgery, University of Rome "La Sapienza," Policlinico Umberto I, Rome, Italy.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001665-200611000-000
Publisher Site
http://dx.doi.org/10.1097/01.scs.0000249350.59096.d0DOI Listing
November 2006

IgM multiple myeloma: report of four cases and review of the literature.

Leuk Lymphoma 2006 Aug;47(8):1565-9

Ematologia, Università Campus Bio-Medico Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600604450DOI Listing
August 2006